信义光能（0968.HK） 2026-03-04 星期三 | 目标价： | 3.60 | 港元 | | --- | --- | --- | | 现价： | 3.11 | 港元 | | 预计升幅： | 16% | | 数据来源 :Wind 、国元证券经纪 ( 香港 ) 整理 主要股东 信义玻璃控股有限公司 (23.82%) 李贤义及关连人士 (9.99%) 相关报告 首次报告-20200618 更新报告- 20200804/20201221/20210308 更新报告-20210817/1222 更新报告-20220310/0805/1130 更新报告-20230516/20240311/0806 更新报告-20250107/0612/0804 研究部 姓名：杨义琼 SFC：AXU943 电话：0755-21516065 Email：yangyq@gyzq.com.hk 持有 海外销售支撑业绩，静待行业底部回暖 重要数据 | 日期 | 2026-3-3 | | --- | --- | | 收盘价(港元) | 3.11 | | 总股本(亿股) | 91.47 | | 总市值(亿港元) | 284 | | 净资产( ...

信义光能 20260228 摘要 信义玻璃 2025 年纯利同比下降 15.5%至人民币 8.4 亿元，主要受多晶 硅及太阳能生产线减值影响；剔除减值因素，基本利润表现显著改善。 综合毛利同比增长 15.4%至人民币 44.61 亿元，综合毛利率提升至 21.4%。 太阳能玻璃业务收入同比下降 5.3%至人民币 178.3 亿元，但毛利同比 提升 38.1%至约人民币 25.10 亿元，毛利率为 14.1%。海外销售同比 增长 36%，主要由美国及印度市场推动，海外市场具备价格溢价。 可再生能源业务发电收入同比轻微下跌 0.8%至约人民币 29.9 亿元，毛 利同比下降 4.6%至约人民币 19.38 亿元，主要受限电影响。2025 年 无新增项目并网，对新项目投资采取审慎态度。 截至 2025 年底，公司净负债率显著下降至 20.1%，若不计入信义能源， 则为 2.8%。经营活动产生的现金净额为人民币 53.27 亿元，银行现金 结余约人民币 51.58 亿元。2025 年资本支出约人民币 25.31 亿元，主 要用于产能扩张及升级。 Q&A 2025 年信义光能整体经营业绩与利润变动的核心驱动因素是什么， ...

信义光能（00968）公布2025年业绩，收益约208.61亿元，同比减少4.8%；公司权益持有人应占溢利 8.445亿元，同比减少16.2%；每股基本盈利9.29分，拟派每股末期股息0.8港仙。 公告称，收入减少主要原因是即使太阳能玻璃产品销售量达到高于去年的水平，但平均售价有所下降。 溢利减少主要源于固定资产减值拨备的增加。 责任编辑：卢昱君 信义光能（00968）公布2025年业绩，收益约208.61亿元，同比减少4.8%；公司权益持有人应占溢利 8.445亿元，同比减少16.2%；每股基本盈利9.29分，拟派每股末期股息0.8港仙。 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 公告称，收入减少主要原因是即使太阳能玻璃产品销售量达到高于去年的水平，但平均售价有所下降。 溢利减少主要源于固定资产减值拨备的增加。 责任编辑：卢昱君 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 ...

Performance Summary - Xinyi Solar (00968.HK) reported a revenue of 20.861 billion yuan for 2025, a decrease of 4.8% year-on-year, with a net profit of 844.5 million yuan, down 16.2%, primarily due to a decline in average selling prices of solar glass products [2] - Zhongxin Innovation (03931.HK) expects a net profit of 2.025 billion to 2.193 billion yuan for 2025, an increase of approximately 140% to 160% compared to the previous year, driven by high growth in leading technology products across passenger, commercial, and energy storage sectors [2] - Rongchang Bio (09995.HK) anticipates a revenue of 3.251 billion yuan for 2025, an increase of 89.36% year-on-year, with a net profit of 709 million yuan, turning profitable due to increased sales of Tislelizumab and injection-use Vedolizumab [2] - Xinyi Energy (03868.HK) expects a revenue of 2.453 billion yuan for 2025, a slight increase of 0.53%, with a net profit of 1.011 billion yuan, up 27.79% [2] - Sihang Property (00083.HK) reported a revenue of 5.185 billion HKD for the six months ending December 31, 2025, an increase of 34.54%, while net profit decreased by 15.77% to 1.533 billion HKD [3] - Haohai Biological Technology (06826.HK) expects a revenue of approximately 2.473 billion yuan for 2025, a decrease of 8.33%, with a net profit of about 251 million yuan, down 40.3% [4] - Chunli Medical (01858.HK) anticipates a total revenue of approximately 1.044 billion yuan for 2025, a year-on-year increase of 29.52%, with a net profit of 272 million yuan, up 117.72% [5] - Baosheng International (03813.HK) issued a profit warning, expecting a net profit of approximately 211 million yuan for 2025, a decrease of about 57.1% [6] - Chip Intelligence Holdings (02166.HK) expects a net profit of approximately 140 million to 170 million HKD for 2025, an increase of about 40% to 70%, benefiting from the booming AI technology and increasing market demand [6] - Fengcai Technology (01304.HK) anticipates a total revenue of approximately 774 million yuan for 2025, a year-on-year increase of 28.91%, with a net profit of about 227 million yuan, up 1.92% [6] - Huayou Energy (01251.HK) issued a profit warning, expecting a loss of approximately 100 million to 150 million HKD for the 2025 fiscal year [7] - Zhoneng Group (00131.HK) reported a revenue of 272 million HKD for the six months ending December 31, 2025, an increase of 250.64%, with a net profit of 180 million HKD, turning profitable [8] - Fudan Zhangjiang (01349.HK) expects a revenue of approximately 686 million yuan for 2025, a decrease of 3.33%, with a net loss of approximately 157 million yuan, turning from profit to loss [9] Company News - Bay Area Development (00737.HK) reported that the total toll revenue for January from the Guangzhou-Shenzhen Expressway, Guangzhou-Zhuhai West Line Expressway, and the Shenzhen section of the Yangtze River Expressway was approximately 241 million, 105 million, and 75.169 million yuan, respectively, representing year-on-year growth of 15%, 17%, and 19% [10] - LeCang Logistics (02490.HK) plans to acquire two large container ships [10] - Innovent Biologics (01801) received approval for Jebatuzumab (Pimobendan) in China for the indication of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma [11] Buyback Activities - Xiaomi Group-W (01810.HK) repurchased 2.8582 million shares for a total of approximately 99.9973 million HKD, with a repurchase price ranging from 34.92 to 35.04 HKD per share [12] - Geely Automobile (00175.HK) repurchased 3.673 million shares for approximately 59.4327 million HKD, with a repurchase price between 16.1 and 16.3 HKD [13] - Miniso Group (09896.HK) repurchased approximately 0.0526 million shares for about 1.8893 million HKD, with a repurchase price ranging from 35.64 to 36.34 HKD [14] - NetEase Cloud Music (09899.HK) repurchased approximately 0.09715 million shares for about 14.9959 million HKD, with an average repurchase price of 154.36 HKD [14]

信义光能(00968)公布2025年业绩，收益约208.61亿元，同比减少4.8%;公司权益持有人应占溢利8.445亿 元，同比减少16.2%;每股基本盈利9.29分，拟派每股末期股息0.8港仙。 公告称，收入减少主要原因是即使太阳能玻璃产品销售量达到高于去年的水平，但平均售价有所下降。 溢利减少主要源于固定资产减值拨备的增加。 ...

公告称，收入减少主要原因是即使太阳能玻璃产品销售量达到高于去年的水平，但平均售价有所下降。 溢利减少主要源于固定资产减值拨备的增加。 智通财经APP讯，信义光能(00968)公布2025年业绩，收益约208.61亿元，同比减少4.8%;公司权益持有 人应占溢利8.445亿元，同比减少16.2%;每股基本盈利9.29分，拟派每股末期股息0.8港仙。 ...

机构持仓方面，截止2025年9月30日，南玻A十大流通股东中，香港中央结算有限公司位居第六大流通 股东，持股2178.68万股，相比上期增加386.24万股。招商证券(香港)有限公司位居第十大流通股东，持 股1691.04万股，相比上期减少208.88万股。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 资金流向方面，主力资金净流出832.03万元，特大单买入361.86万元，占比3.21%，卖出852.24万元，占 比7.56%；大单买入2139.42万元，占比18.98%，卖出2481.07万元，占比22.01%。 南玻A所属申万行业为：建筑材料-玻璃玻纤-玻璃制造。所属概念板块包括：建筑节能概念、低辐射玻 璃、BIPV概念(光伏建筑一体化)、低价、光伏玻璃等。 截至1月30日，南玻A股东户数12.35万，较上期减少0.92%；人均流通股21479股，较上期增加1.20%。 2025年1月-9月，南玻A实现营业收入104.24亿 ...

Group 1 - The core viewpoint of the news is that Amatone's stock has experienced significant fluctuations, with a year-to-date increase of 66.85% and a recent drop of 2.49% [1] - As of February 10, Amatone's stock price is 30.20 yuan per share, with a total market capitalization of 6.012 billion yuan [1] - The company has seen a net outflow of main funds amounting to 1.0232 million yuan, with large orders showing mixed buying and selling activity [1] Group 2 - Amatone, established on September 11, 2006, specializes in the research and production of photovoltaic glass coating materials, with 85.54% of its revenue coming from solar glass [2] - The company operates in the photovoltaic equipment sector and is involved in various concepts such as BIPV and perovskite batteries [2] - As of September 30, 2025, Amatone reported a revenue of 1.58 billion yuan, a year-on-year decrease of 35.42%, and a net profit loss of 59.57 million yuan, down 123.67% [2] Group 3 - Amatone has distributed a total of 319 million yuan in dividends since its A-share listing, with 232 million yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders increased by 25.12% to 31,500, while the average circulating shares per person decreased by 20.08% to 6,308 shares [2]

融资方面，亚玛顿当日融资买入6496.47万元。当前融资余额1.36亿元，占流通市值的2.64%，融资余额 超过近一年90%分位水平，处于高位。 2月3日，亚玛顿涨7.48%，成交额7.66亿元。两融数据显示，当日亚玛顿获融资买入额6496.47万元，融 资偿还6812.01万元，融资净买入-315.54万元。截至2月3日，亚玛顿融资融券余额合计1.36亿元。 融券方面，亚玛顿2月3日融券偿还2500.00股，融券卖出200.00股，按当日收盘价计算，卖出金额 5174.00元；融券余量1.05万股，融券余额27.16万元，超过近一年90%分位水平，处于高位。 资料显示，常州亚玛顿股份有限公司位于江苏省常州市天宁区青龙东路616号，成立日期2006年9月11 日，上市日期2011年10月13日，公司主营业务涉及光伏玻璃镀膜材料技术和工艺技术的研发,光伏玻璃 的镀膜生产以及光伏镀膜玻璃销售。主营业务收入构成为：太阳能玻璃85.54%，电子玻璃及其他玻璃 产品10.99%，电力销售2.27%，太阳能组件0.80%，其他0.40%。 截至9月30日，亚玛顿股东户数3.15万，较上期增加25.12%；人均流通股630 ...

1月30日，亚玛顿跌4.93%，成交额5.03亿元。两融数据显示，当日亚玛顿获融资买入额3656.41万元， 融资偿还3251.94万元，融资净买入404.47万元。截至1月30日，亚玛顿融资融券余额合计1.30亿元。 融资方面，亚玛顿当日融资买入3656.41万元。当前融资余额1.29亿元，占流通市值的2.65%，融资余额 超过近一年90%分位水平，处于高位。 截至9月30日，亚玛顿股东户数3.15万，较上期增加25.12%；人均流通股6308股，较上期减少20.08%。 2025年1月-9月，亚玛顿实现营业收入15.80亿元，同比减少35.42%；归母净利润-5957.04万元，同比减 少123.67%。 分红方面，亚玛顿A股上市后累计派现3.19亿元。近三年，累计派现2.32亿元。 机构持仓方面，截止2025年9月30日，亚玛顿十大流通股东中，金元顺安元启灵活配置混合（004685） 退出十大流通股东之列。 融券方面，亚玛顿1月30日融券偿还700.00股，融券卖出500.00股，按当日收盘价计算，卖出金额1.22万 元；融券余量1.49万股，融券余额36.48万元，超过近一年90%分位水平，处于高位。 ...